Utilization ofglutathione S-transferase Mu 1- andTheta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utilization ofglutathione S-transferase Mu 1- andTheta 1-null mice as animal models for absorption, distribution, metabolism, excretion and toxicity studies
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 9, Issue 6, Pages 725-736
Publisher
Informa Healthcare
Online
2013-03-19
DOI
10.1517/17425255.2013.780027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PHASE II DRUG METABOLIZING ENZYMES
- (2012) Petra Jancova et al. BIOMEDICAL PAPERS-OLOMOUC
- Resistance to acetaminophen-induced hepatotoxicity in glutathione S-transferase Mu 1-null mice
- (2012) Shingo Arakawa et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Knockout and transgenic mice in glutathione transferase research
- (2011) Colin J. Henderson et al. DRUG METABOLISM REVIEWS
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
- (2011) Q. Ma et al. PHARMACOLOGICAL REVIEWS
- Humanizing π-Class Glutathione S-Transferase Regulation in a Mouse Model Alters Liver Toxicity in Response to Acetaminophen Overdose
- (2011) Matthew P. Vaughn et al. PLoS One
- Transgenic Animal Models in Toxicology: Historical Perspectives and Future Outlook
- (2011) Darrell R. Boverhof et al. TOXICOLOGICAL SCIENCES
- Pharmacogenomics in Drug Induced Liver Injury
- (2010) Raul Andrade et al. CURRENT DRUG METABOLISM
- Methemoglobinemia Induced by 1,2-Dichloro-4-nitrobenzene in Mice with a Disrupted Glutathione S-Transferase Mu 1 Gene
- (2010) S. Arakawa et al. DRUG METABOLISM AND DISPOSITION
- A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation
- (2010) H. Cai et al. DRUG METABOLISM AND DISPOSITION
- Drug-Induced Idiosyncratic Hepatotoxicity: Prevention Strategy Developed after the Troglitazone Case
- (2010) Toshihiko Ikeda Drug Metabolism and Pharmacokinetics
- Pharmacogenetics of drug-induced liver injury
- (2010) Stefan Russmann et al. HEPATOLOGY
- Structural determinants in domain II of human glutathione transferase M2-2 govern the characteristic activities with aminochrome, 2-cyano-1, 3-dimethyl-1-nitrosoguanidine, and 1, 2-dichloro-4-nitrobenzene
- (2009) Lars O. Hansson et al. PROTEIN SCIENCE
- Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1
- (2009) Zoran Ilic et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical
- (2008) Michael Sinz et al. AAPS Journal
- Glutathione-S-transferase (GST) M1 null genotype and combined GSTM1 and GSTT1 null genotypes are risk factors for increased serum γ-glutamyltransferase in valproic acid-treated patients
- (2008) Yumi Fukushima et al. CLINICA CHIMICA ACTA
- Structure, Function and Polymorphism of Human Cytosolic Sulfotransferases
- (2008) Yong Li et al. CURRENT DRUG METABOLISM
- GlutathioneS-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
- (2008) M. Isabel Lucena et al. HEPATOLOGY
- Apoptosis Signal-Regulating Kinase 1 in Stress and Immune Response
- (2007) Kohsuke Takeda et al. Annual Review of Pharmacology and Toxicology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started